Test Determines Benefit of Chemotherapy For Breast Cancer

There's a relatively new cancer test that assesses the likelihood that breast cancer will recur and it can also provide information as to whether a patient will benefit chemotherapy. This called the Oncotype DX Test. The studies for this began in 2004, and after evaluating patients who took this test, it was found that about half the patients would not benefit from chemotherapy. Prior to this test, all patients would have been given chemo as a matter of course. This test is only effective for those patients that do not have lymph node involvement and whose cancer is hormone receptor positive. This type of breast cancer is the most common, so this test will benefit the most people. For more information, search the web using "Oncotype DX" for a plethora of articles.

Add comment

Security code

Product Categories

My Shopping Cart

Show Cart
Your Cart is currently empty.

Advanced Search


"I love the faux fur fleece hats & blue sailor hat (my all time favorite!)."

- Sandra H.